CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Total Current Liabilities Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Total Current Liabilities
kr127m
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Elekta AB (publ)
STO:EKTA B
Total Current Liabilities
kr14B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Current Liabilities
kr256.3m
CAGR 3-Years
61%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Total Current Liabilities
kr13.2B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Current Liabilities
kr4.4B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Current Liabilities
kr183.8m
CAGR 3-Years
84%
CAGR 5-Years
43%
CAGR 10-Years
28%

See Also

What is CellaVision AB's Total Current Liabilities?
Total Current Liabilities
127m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Total Current Liabilities amounts to 127m SEK.

What is CellaVision AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%

Over the last year, the Total Current Liabilities growth was -4%. The average annual Total Current Liabilities growth rates for CellaVision AB have been 1% over the past three years , 11% over the past five years , and 13% over the past ten years .

Back to Top